FFCP PHASE1:Mm9::chr13:93581759..93581760,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=1657|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr13:93581759..93581760,+|id=chr13:93581759..93581760,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0002476,9.49e-16,2;CL:0000764,4.56e-11,3;CL:0000765,4.56e-11,3;CL:0000038,4.56e-11,3;CL:0000547,4.56e-11,3;CL:0000839,4.49e-10,13;CL:0002194,1.46e-08,4;CL:0000766,1.46e-08,4;CL:0000234,1.46e-08,4;CL:0000576,1.46e-08,4;CL:0000235,1.46e-08,4;CL:0000864,1.46e-08,4;CL:0002009,1.46e-08,4;CL:0000040,1.46e-08,4;CL:0000559,1.46e-08,4;CL:0000763,2.16e-08,16;CL:0000049,3.11e-07,19|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=DOID:2531,4.56e-11,3;DOID:0060083,4.56e-11,3;DOID:1240,4.56e-11,3|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0.348975407639361,0,0,0.500895729946347,0,0,0,0,0,0,0,0,0.174840804837995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.190023419456374,0,0.221730510655305,3.81018404075779,0,0,0,0.166234645358492,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.286533439938757,0,0.202316460859598,0,0.633831403506179,0,0,0,0.988866362566974,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.15279824777681,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.35333957451034,0,0,0,0,0,0.253359865475099,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164698954724011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.01582567878545,0.54390568381871,0,0,0,0,0,0,0,0,0,0,0,0.283076530788832,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.104859344425711,0,0.288030006257865,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221985953374065,0,0,0,0,0,0,0,0,0,0,1.89038500578056,0,0.755393897389701,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.233931608445408,0,0,0,0|short_description=p@chr13:93581759..93581760,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=1657 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:93581759..93581760,+ | |||
|description=CAGE_peak_at_chr13:93581759..93581760,+ | |||
|id=chr13:93581759..93581760,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0002476,9.49e-16,2;CL:0000764,4.56e-11,3;CL:0000765,4.56e-11,3;CL:0000038,4.56e-11,3;CL:0000547,4.56e-11,3;CL:0000839,4.49e-10,13;CL:0002194,1.46e-08,4;CL:0000766,1.46e-08,4;CL:0000234,1.46e-08,4;CL:0000576,1.46e-08,4;CL:0000235,1.46e-08,4;CL:0000864,1.46e-08,4;CL:0002009,1.46e-08,4;CL:0000040,1.46e-08,4;CL:0000559,1.46e-08,4;CL:0000763,2.16e-08,16;CL:0000049,3.11e-07,19 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2=DOID:2531,4.56e-11,3;DOID:0060083,4.56e-11,3;DOID:1240,4.56e-11,3 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0.348975407639361,0,0,0.500895729946347,0,0,0,0,0,0,0,0,0.174840804837995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.190023419456374,0,0.221730510655305,3.81018404075779,0,0,0,0.166234645358492,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.286533439938757,0,0.202316460859598,0,0.633831403506179,0,0,0,0.988866362566974,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.15279824777681,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.35333957451034,0,0,0,0,0,0.253359865475099,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164698954724011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.01582567878545,0.54390568381871,0,0,0,0,0,0,0,0,0,0,0,0.283076530788832,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.104859344425711,0,0.288030006257865,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221985953374065,0,0,0,0,0,0,0,0,0,0,1.89038500578056,0,0.755393897389701,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.233931608445408,0,0,0,0 | |||
|short_description=p@chr13:93581759..93581760,+ | |||
}} |
Latest revision as of 10:08, 6 August 2015
Short description: | p@chr13:93581759..93581760, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr13:93581759..93581760, + |
Coexpression cluster: | MCL_coexpression_mm9:1657 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
bone marrow macrophage | 9.49e-16 | 2 |
erythroid lineage cell | 4.56e-11 | 3 |
erythroblast | 4.56e-11 | 3 |
erythroid progenitor cell | 4.56e-11 | 3 |
proerythroblast | 4.56e-11 | 3 |
myeloid lineage restricted progenitor cell | 4.49e-10 | 13 |
monopoietic cell | 1.46e-08 | 4 |
myeloid leukocyte | 1.46e-08 | 4 |
phagocyte | 1.46e-08 | 4 |
monocyte | 1.46e-08 | 4 |
macrophage | 1.46e-08 | 4 |
tissue-resident macrophage | 1.46e-08 | 4 |
macrophage dendritic cell progenitor | 1.46e-08 | 4 |
monoblast | 1.46e-08 | 4 |
promonocyte | 1.46e-08 | 4 |
myeloid cell | 2.16e-08 | 16 |
common myeloid progenitor | 3.11e-07 | 19 |
Ontology term | p-value | n |
---|---|---|
hematologic cancer | 4.56e-11 | 3 |
immune system cancer | 4.56e-11 | 3 |
leukemia | 4.56e-11 | 3 |